MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
45 hedge funds and large institutions have $50M invested in Merrimack Pharmaceuticals, Inc. in 2021 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
9% less capital invested
Capital invested by funds: $55.2M → $50M (-$5.16M)
32% less call options, than puts
Call options by funds: $669K | Put options by funds: $991K
Holders
45
Holding in Top 10
1
Calls
$669K
Puts
$991K
Top Buyers
| 1 | +$225K | |
| 2 | +$182K | |
| 3 | +$176K | |
| 4 |
SC
Sepio Capital
Salt Lake City,
Utah
|
+$160K |
| 5 |
Bank of New York Mellon
New York
|
+$155K |
Top Sellers
| 1 | -$897K | |
| 2 | -$389K | |
| 3 | -$319K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$197K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$7.51K |